149 related articles for article (PubMed ID: 21801201)
21. Effects of Ezetimibe, Simvastatin, and their Combination on Inflammatory Parameters in a Rat Model of Adjuvant-Induced Arthritis.
Barbosa CP; Bracht L; Ames FQ; de Souza Silva-Comar FM; Tronco RP; Bersani-Amado CA
Inflammation; 2017 Apr; 40(2):717-724. PubMed ID: 28028755
[TBL] [Abstract][Full Text] [Related]
22. Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) study.
Ballantyne CM; Abate N; Yuan Z; King TR; Palmisano J
Am Heart J; 2005 Mar; 149(3):464-73. PubMed ID: 15864235
[TBL] [Abstract][Full Text] [Related]
23. Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease.
Barrios V; Amabile N; Paganelli F; Chen JW; Allen C; Johnson-Levonas AO; Massaad R; Vandormael K
Int J Clin Pract; 2005 Dec; 59(12):1377-86. PubMed ID: 16351668
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome.
Van Rooyen DM; Gan LT; Yeh MM; Haigh WG; Larter CZ; Ioannou G; Teoh NC; Farrell GC
J Hepatol; 2013 Jul; 59(1):144-52. PubMed ID: 23500152
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients.
Athyros VG; Tziomalos K; Kakafika AI; Koumaras H; Karagiannis A; Mikhailidis DP
Am J Cardiol; 2008 Feb; 101(4):483-5. PubMed ID: 18312762
[TBL] [Abstract][Full Text] [Related]
26. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
Ballantyne CM; Houri J; Notarbartolo A; Melani L; Lipka LJ; Suresh R; Sun S; LeBeaut AP; Sager PT; Veltri EP;
Circulation; 2003 May; 107(19):2409-15. PubMed ID: 12719279
[TBL] [Abstract][Full Text] [Related]
27. Effect of atorvastatin with or without prednisolone on Freund's adjuvant induced-arthritis in rats.
Abdin AA; Abd El-Halim MS; Hedeya SE; El-Saadany AA
Eur J Pharmacol; 2012 Feb; 676(1-3):34-40. PubMed ID: 22197001
[TBL] [Abstract][Full Text] [Related]
28. Effects of simvastatin, ezetimibe, and their combination on histopathologic alterations caused by adjuvant-induced arthritis.
Barbosa CP; Ritter AM; da Silva LG; Grespan R; Cuman RK; Hernandes L; Bersani-Amado CA
Inflammation; 2014 Aug; 37(4):1035-43. PubMed ID: 24493323
[TBL] [Abstract][Full Text] [Related]
29. Attainment of Canadian and European guidelines' lipid targets with atorvastatin plus ezetimibe vs. doubling the dose of atorvastatin.
Leiter LA; Bays H; Conard S; Lin J; Hanson ME; Shah A; Tershakovec AM
Int J Clin Pract; 2010 Dec; 64(13):1765-72. PubMed ID: 20946261
[TBL] [Abstract][Full Text] [Related]
30. The effects of low-dose simvastatin and ezetimibe compared to high-dose simvastatin alone on post-fat load endothelial function in patients with metabolic syndrome: a randomized double-blind crossover trial.
Olijhoek JK; Hajer GR; van der Graaf Y; Dallinga-Thie GM; Visseren FL
J Cardiovasc Pharmacol; 2008 Aug; 52(2):145-50. PubMed ID: 18670365
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis.
Barsante MM; Roffê E; Yokoro CM; Tafuri WL; Souza DG; Pinho V; Castro MS; Teixeira MM
Eur J Pharmacol; 2005 Jun; 516(3):282-9. PubMed ID: 15970284
[TBL] [Abstract][Full Text] [Related]
32. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the effects of combination atorvastatin (40 mg) + ezetimibe (10 mg) versus atorvastatin (40 mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent.
Azar M; Valentin E; Badaoui G; Kassab R; Sarkis A; Azar RR
Am J Cardiol; 2011 Jun; 107(11):1571-4. PubMed ID: 21439529
[TBL] [Abstract][Full Text] [Related]
34. Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipedemia.
Lee SH; Park S; Kang SM; Jang Y; Chung N; Choi D
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):65-71. PubMed ID: 21386036
[TBL] [Abstract][Full Text] [Related]
35. [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl].
MMW Fortschr Med; 2004 Oct; 146(44):57. PubMed ID: 15566254
[No Abstract] [Full Text] [Related]
36. Improved endothelial function with simvastatin but unchanged insulin sensitivity with simvastatin or ezetimibe.
Kater AL; Batista MC; Ferreira SR
Metabolism; 2010 Jun; 59(6):921-6. PubMed ID: 20199786
[TBL] [Abstract][Full Text] [Related]
37. Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin.
Farnier M
Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():27-8. PubMed ID: 18001317
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.
Abel T; Fehér J; Dinya E; Eldin MG; Kovács A
Med Sci Monit; 2009 Dec; 15(12):MS6-11. PubMed ID: 19946244
[TBL] [Abstract][Full Text] [Related]
39. Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study).
Zieve F; Wenger NK; Ben-Yehuda O; Constance C; Bird S; Lee R; Hanson ME; Jones-Burton C; Tershakovec AM
Am J Cardiol; 2010 Mar; 105(5):656-63. PubMed ID: 20185012
[TBL] [Abstract][Full Text] [Related]
40. Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe.
van Heyningen C
Ann Clin Biochem; 2005 Sep; 42(Pt 5):402-4. PubMed ID: 16168199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
